Authors:
MORISAKI T
MORTON DL
UCHIYAMA A
YUZUKI D
BARTH A
HOON DSB
Citation: T. Morisaki et al., CHARACTERIZATION AND AUGMENTATION OF CD4-CELL LINES AGAINST MELANOMA(CYTOTOXIC T), Cancer immunology and immunotherapy, 39(3), 1994, pp. 172-178
Citation: B. Schuurman et al., ENHANCED KILLING CAPACITY OF HUMAN KUPFFER CELLS AFTER ACTIVATION WITH HUMAN GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR AND INTERFERON-GAMMA, Cancer immunology and immunotherapy, 39(3), 1994, pp. 179-184
Authors:
LELANN AD
FOURNIE GJ
BOISSIER L
TOUTAIN PL
BENOIST H
Citation: Ad. Lelann et al., IN-VITRO INHIBITION OF NATURAL-KILLER-MEDIATED LYSIS BY CHROMATIN FRAGMENTS, Cancer immunology and immunotherapy, 39(3), 1994, pp. 185-192
Authors:
BOIARDI A
SILVANI A
RUFFINI PA
RIVOLTINI L
PARMIANI G
BROGGI G
SALMAGGI A
Citation: A. Boiardi et al., LOCO-REGIONAL IMMUNOTHERAPY WITH RECOMBINANT INTERLEUKIN-2 AND ADHERENT LYMPHOKINE-ACTIVATED KILLER-CELLS (A-LAK) IN RECURRENT GLIOBLASTOMAPATIENTS, Cancer immunology and immunotherapy, 39(3), 1994, pp. 193-197
Authors:
CHAPMAN PB
GILLIES SD
HOUGHTON AN
REILLY RM
Citation: Pb. Chapman et al., MAPPING EFFECTOR FUNCTIONS OF A MONOCLONAL-ANTIBODY TO GD3 BY CHARACTERIZATION OF A MOUSE-HUMAN CHIMERIC ANTIBODY, Cancer immunology and immunotherapy, 39(3), 1994, pp. 198-204
Authors:
VINCENT F
LEVY V
BENSOUSAN TA
GLOTZ D
DUBOUST A
ESCUDIER B
LECLERCQ B
Citation: F. Vincent et al., SPONTANEOUS REGRESSIONS OF A METASTATIC ADENOCARCINOMA TRANSMITTED BYA CADAVER KIDNEY GRAFT - SUPPORT FOR IMMUNOTHERAPY, Cancer immunology and immunotherapy, 39(3), 1994, pp. 205-206
Authors:
SHAMAMIAN P
MANCINI M
KAWAKAMI Y
RESTIFO NP
ROSENBERG SA
TOPALIAN SL
Citation: P. Shamamian et al., RECOGNITION OF NEUROECTODERMAL TUMORS BY MELANOMA-SPECIFIC CYTOTOXIC T-LYMPHOCYTES - EVIDENCE FOR ANTIGEN SHARING BY TUMORS DERIVED FROM THE NEURAL CREST, Cancer immunology and immunotherapy, 39(2), 1994, pp. 73-83
Authors:
HELFAND SC
SOERGEL SA
MACWILLIAMS PS
HANK JA
SONDEL PM
Citation: Sc. Helfand et al., CLINICAL AND IMMUNOLOGICAL EFFECTS OF HUMAN RECOMBINANT INTERLEUKIN-2GIVEN BY REPETITIVE WEEKLY INFUSION TO NORMAL DOGS, Cancer immunology and immunotherapy, 39(2), 1994, pp. 84-92
Authors:
HERR W
WOLFEL T
HEIKE M
ZUMBUSCHENFELDE KHM
KNUTH A
Citation: W. Herr et al., FREQUENCY-ANALYSIS OF TUMOR-REACTIVE CYTOTOXIC T-LYMPHOCYTES IN PERIPHERAL-BLOOD OF A MELANOMA PATIENT VACCINATED WITH AUTOLOGOUS TUMOR-CELLS, Cancer immunology and immunotherapy, 39(2), 1994, pp. 93-99
Citation: S. Clark et al., EFFECT OF INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA ON SENSITIVITY TO CISPLATIN IN OVARIAN-CARCINOMA CELL-LINES, Cancer immunology and immunotherapy, 39(2), 1994, pp. 100-104
Authors:
SALGALLER ML
WEBER JS
KOENIG S
YANNELLI JR
ROSENBERG SA
Citation: Ml. Salgaller et al., GENERATION OF SPECIFIC ANTIMELANOMA REACTIVITY BY STIMULATION OF HUMAN TUMOR-INFILTRATING LYMPHOCYTES WITH MAGE-1 SYNTHETIC PEPTIDE, Cancer immunology and immunotherapy, 39(2), 1994, pp. 105-116
Citation: L. Gorelik et al., LOW-DOSE MELPHALAN-INDUCED SHIFT IN THE PRODUCTION OF A TH2-TYPE CYTOKINE TO A TH1-TYPE CYTOKINE IN MICE BEARING A LARGE MOPC-315 TUMOR, Cancer immunology and immunotherapy, 39(2), 1994, pp. 117-126
Authors:
CHONG ASF
JIANG XL
SCUDERI P
LAMAS M
GRAF LH
Citation: Asf. Chong et al., ICAM-1 AND LFA-3 ENHANCE THE ABILITY OF ANTI-CD3 MAB TO STIMULATE INTERFERON-GAMMA PRODUCTION IN INTERLEUKIN-2-ACTIVATED T-CELLS, Cancer immunology and immunotherapy, 39(2), 1994, pp. 127-134
Citation: Aj. Rowland et Ga. Pietersz, REDUCTION IN THE TOXICITY OF AMINOPTERIN - MONOCLONAL-ANTIBODY CONJUGATES BY LEUCOVORIN, Cancer immunology and immunotherapy, 39(2), 1994, pp. 135-139
Citation: Tl. Whiteside et G. Parmiani, TUMOR-INFILTRATING LYMPHOCYTES - THEIR PHENOTYPE, FUNCTIONS AND CLINICAL USE, Cancer immunology and immunotherapy, 39(1), 1994, pp. 15-21
Authors:
YANASE M
TSUKAMOTO T
KUMAMOTO Y
KATO K
HASHIMOTO Y
Citation: M. Yanase et al., DECREASE IN LYMPHOKINE-ACTIVATED KILLER SENSITIVITY OF A HUMAN RENAL-CELL CARCINOMA CELL-LINE AFTER CYTOKINE TREATMENT, Cancer immunology and immunotherapy, 39(1), 1994, pp. 22-26
Citation: S. Caplan et al., CHARACTERIZATION AND PURIFICATION OF A MYCOPLASMA MEMBRANE-DERIVED MACROPHAGE-ACTIVATING FACTOR, Cancer immunology and immunotherapy, 39(1), 1994, pp. 27-33
Citation: Pa. Palmer et al., PERSISTENT AUGMENTATION OF NATURAL-KILLER-MEDIATED AND T-CELL-MEDIATED CYTOTOXICITY IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS PULSED IN-VITRO WITH HIGH-DOSE RECOMBINANT INTERLEUKIN-2 PRIOR TO CULTURING WITH A LOW MAINTENANCE DOSE, Cancer immunology and immunotherapy, 39(1), 1994, pp. 34-40
Citation: Db. Ring et al., ANTIGEN FORKS - BISPECIFIC REAGENTS THAT INHIBIT CELL-GROWTH BY BINDING SELECTED PAIRS OF TUMOR-ANTIGENS, Cancer immunology and immunotherapy, 39(1), 1994, pp. 41-48
Authors:
HILL FWG
RUTTEN VPMG
HOYER MH
KLEIN WR
KOTEN JW
STEERENBERG PA
RUITENBERG EJ
DENOTTER W
Citation: Fwg. Hill et al., LOCAL BACILLUS-CALMETTE-GUERIN THERAPY FOR BOVINE VULVAR PAPILLOMA AND CARCINOMA, Cancer immunology and immunotherapy, 39(1), 1994, pp. 49-52
Authors:
LEGERRAVET MB
MATHIOT C
PORTIER A
BRANDELY M
GALANAUD P
FRIDMAN WH
EMILIE D
Citation: Mb. Legerravet et al., INCREASED EXPRESSION OF PERFORIN AND GRANZYME-B GENES IN PATIENTS WITH METASTATIC MELANOMA TREATED WITH RECOMBINANT INTERLEUKIN-2, Cancer immunology and immunotherapy, 39(1), 1994, pp. 53-58
Authors:
TALMADGE JE
JACKSON JD
BORGESON CD
PERRY GA
Citation: Je. Talmadge et al., DIFFERENTIAL RECOVERY OF POLYMORPHONUCLEAR NEUTROPHILS, B-CELL AND T-CELL SUBPOPULATIONS IN THE THYMUS, BONE-MARROW, SPLEEN AND BLOOD OF MICE FOLLOWING SPLIT-DOSE POLYCHEMOTHERAPY, Cancer immunology and immunotherapy, 39(1), 1994, pp. 59-67
Citation: Ame. Nouri et al., CLINICAL AND IMMUNOLOGICAL EFFECT OF INTRAVESICAL INTERLEUKIN-2 ON SUPERFICIAL BLADDER-CANCER, Cancer immunology and immunotherapy, 39(1), 1994, pp. 68-70
Citation: Z. Gazit et E. Kedar, CHEMOTHERAPY-INDUCED MODULATION OF NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY IN EUTHYMIC AND ATHYMIC MICE (VOL 38, PG 243, 1994), Cancer immunology and immunotherapy, 39(1), 1994, pp. 71-71